BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31004968)

  • 1.
    Ludvigsen TP; Pedersen SF; Vegge A; Ripa RS; Johannesen HH; Hansen AE; Löfgren J; Schumacher-Petersen C; Kirk RK; Pedersen HD; Christoffersen BØ; Ørbæk M; Forman JL; Klausen TL; Olsen LH; Kjaer A
    Atherosclerosis; 2019 Jun; 285():55-63. PubMed ID: 31004968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
    Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
    Millon A; Dickson SD; Klink A; Izquierdo-Garcia D; Bini J; Lancelot E; Ballet S; Robert P; Mateo de Castro J; Corot C; Fayad ZA
    Atherosclerosis; 2013 Jun; 228(2):339-45. PubMed ID: 23582588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
    Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A
    Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI.
    Fernández-Friera L; Fuster V; López-Melgar B; Oliva B; Sánchez-González J; Macías A; Pérez-Asenjo B; Zamudio D; Alonso-Farto JC; España S; Mendiguren J; Bueno H; García-Ruiz JM; Ibañez B; Fernández-Ortiz A; Sanz J
    J Am Coll Cardiol; 2019 Apr; 73(12):1371-1382. PubMed ID: 30922468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.
    Calcagno C; Lairez O; Hawkins J; Kerr SW; Dugas MS; Simpson T; Epskamp J; Robson PM; Eldib M; Bander I; K-Raman P; Ramachandran S; Pruzan A; Kaufman A; Mani V; Ehlgen A; Niessen HG; Broadwater J; Fayad ZA
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):291-301. PubMed ID: 29413439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F-FDG PET imaging of murine atherosclerosis: association with gene expression of key molecular markers.
    Hag AM; Pedersen SF; Christoffersen C; Binderup T; Jensen MM; Jørgensen JT; Skovgaard D; Ripa RS; Kjaer A
    PLoS One; 2012; 7(11):e50908. PubMed ID: 23226424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging.
    Vucic E; Dickson SD; Calcagno C; Rudd JH; Moshier E; Hayashi K; Mounessa JS; Roytman M; Moon MJ; Lin J; Tsimikas S; Fisher EA; Nicolay K; Fuster V; Fayad ZA
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1100-9. PubMed ID: 21999870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
    Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA
    J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET).
    Graebe M; Pedersen SF; Borgwardt L; Højgaard L; Sillesen H; Kjaer A
    Eur J Vasc Endovasc Surg; 2009 Jun; 37(6):714-21. PubMed ID: 19112034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system.
    Li X; Heber D; Rausch I; Beitzke D; Mayerhoefer ME; Rasul S; Kreissl M; Mitthauser M; Wadsak W; Hartenbach M; Haug A; Zhang X; Loewe C; Beyer T; Hacker M
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1503-12. PubMed ID: 26816195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [¹⁸F]-fluorodeoxyglucose PET imaging of atherosclerosis.
    Blomberg BA; Høilund-Carlsen PF
    PET Clin; 2015 Jan; 10(1):1-7. PubMed ID: 25455876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
    Saito H; Kuroda S; Hirata K; Magota K; Shiga T; Tamaki N; Yoshida D; Terae S; Nakayama N; Houkin K
    Cerebrovasc Dis; 2013; 35(4):370-7. PubMed ID: 23635390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques.
    Bala G; Blykers A; Xavier C; Descamps B; Broisat A; Ghezzi C; Fagret D; Van Camp G; Caveliers V; Vanhove C; Lahoutte T; Droogmans S; Cosyns B; Devoogdt N; Hernot S
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):1001-8. PubMed ID: 26800768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
    Huet P; Burg S; Le Guludec D; Hyafil F; Buvat I
    J Nucl Med; 2015 Apr; 56(4):552-9. PubMed ID: 25722452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques.
    Ogawa M; Magata Y; Kato T; Hatano K; Ishino S; Mukai T; Shiomi M; Ito K; Saji H
    J Nucl Med; 2006 Nov; 47(11):1845-50. PubMed ID: 17079818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thresholds for Arterial Wall Inflammation Quantified by
    van der Valk FM; Verweij SL; Zwinderman KA; Strang AC; Kaiser Y; Marquering HA; Nederveen AJ; Stroes ES; Verberne HJ; Rudd JH
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1198-1207. PubMed ID: 27639759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Osteogenesis and Inflammation During the Progression of Calcified Plaque Evaluated by
    Li X; Heber D; Cal-Gonzalez J; Karanikas G; Mayerhoefer ME; Rasul S; Beitzke D; Zhang X; Agis H; Mitterhauser M; Wadsak W; Beyer T; Loewe C; Hacker M
    J Nucl Med; 2017 Jun; 58(6):968-974. PubMed ID: 28232606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.